The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM) , a diversified, vertically integrated global healthcare ...

A young woman has taken to social media to bring awareness to Multiple sclerosis, often shortened to 'MS' after having been ...

Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis ... modifying therapies are now approved to treat MS. The treatments range from oral medications to infusions ...

Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been ...

Having multiple sclerosis (MS) was associated with higher rates of mental illness during the peripartum period than not ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...